24 February 2018
News and Views
Links and Services
A study in the latest issue of the Alimentary Pharmacology & Therapeutics evaluates the performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease.
Several steatosis biomarkers are available with limited independent validation.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors